Aberrant expression of markers of cancer stem cells in gastric adenocarcinoma and their relationship to vasculogenic mimicry

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 10, 2015, Pages 4177-4183

  Zhou, Lei ^a   Yu, Lan ^a   Feng, Zhen Zhong ^a   Gong, Xiao Meng ^a   Cheng, Ze Nong ^a   Yao, Nan ^a   Wang, Dan Na ^a   Wu, Shi Wu ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

CD133; CSCs; Gastric neoplasm; Lgr5; MVD; VM

Indexed keywords

CADHERIN; CD133 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; PEPTIDE; TUMOR MARKER;

ADENOCARCINOMA; CANCER GRADING; CANCER STAGING; CANCER STEM CELL; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SECONDARY; STOMACH; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION; VASCULARIZATION;

ADENOCARCINOMA; ANTIGENS, CD; BIOMARKERS, TUMOR; CADHERINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84930712940     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.10.4177     Document Type: Article

References (54)

1. Ahmadi SA, Moinfar M, Gohari Moghaddam K, Bahadori M (2010). Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med, 13, 498-503.
2. Amsterdam A, Raanan C, Schreiber L, Polin N, Givol D (2013). LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer. Biochem Biophys Res Commun, 433, 157-62.
3. Barker N, Huch M, Kujala P, et al (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell, 6, 25-36.
4. Bu Z, Zheng Z, Zhang L, et al (2013). LGR5 is a promising biomarker for patients with stage I and II gastric cancer. Chin J Cancer Res, 25, 79-89.
5. Curley MD, Therrien VA, Cummings CL, et al (2009). CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 27, 2875-83.
6. Economopoulou P, Kaklamani VG, Siziopikou K (2012). The role of cancer stem cells in breast cancer initiation and progression, potential cancer stem cell-directed therapies. The oncologist. 17, 1394-401.
7. EI Hallani S, Boisselier B, Peglion F, et al (2010). A new alternative mechanism in glioblastoma vascularization, tubular vasculogenic mimicry. Brain, 133, 973-982.
8. Femia AP, Dolara P, Salvadori M, Caderni G (2013). Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazineinduced rat colon carcinogenesis, correlation with nuclear ß-catenin. BMC Cancer, 13, 48.
9. Flesken-Nikitin A, Hwang CI, Cheng CY, et al (2013). Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature, 495, 241-5.
10. Fu D, He X, Yang S, et al (2011). Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro. BMC Musculoskelet Disord, 12, 146.
11. Hashimoto K, Aoyagi K, Isobe T, Kouhuji K, Shirouzu K (2014). Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer, 17, 97-106.
12. Hendrix MJ, Seftor EA, Hess AR, Seftor RE (2003). Vasculogenic mimicry and tumour-cell plasticity, lessons from melanoma. Nat Rev Cancer, 3, 411-21.
13. Hilbe W, Dirnhofer S, Oberwasserlechner F, et al (2004). CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol, 57, 965-9.
14. Huang J, Chen K, Gong W, Dunlop NM, Wang JM (2008). G-protein coupled chemoattractant receptors and cancer. Front Biosci, 13, 3352-63.
15. Immervoll H, Hoem D, Sakariassen PØ, Steffensen OJ, Molven A (2008). Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer, 8, 48.
16. Jiang J, Liu W, Guo X, et al (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30, 4498-508.
17. Li M, Gu Y, Zhang Z, et al (2010). Vasculogenic mimicry, a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res, 16, 259-66.
18. Lin KK, Andersen B (2008). Have hair follicle stem cells shed their tranquil image? Cell Stem Cell, 3, 581-2.
19. Liu TJ, Sun BC, Zhao XL, et al (2013). CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Oncogene, 32, 544-53.
20. Liu Z, Dai W, Jiang L, Cheng Y (2014). Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients. Neoplasma, 61, 177-85.
21. Long H, Xiang T, Qi W, et al (2015). CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget. [Epub ahead of print].
22. Long H, Xie R, Xiang T, et al (2012). Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells, 30, 2309-19.
23. Malanchi I, Santamaria-Martinez A, Susanto E, et al (2012). Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 481, 85-9.
24. Maniotis AJ, Folberg R, Hess A, et al (1999). Vascular channel formation by human melanoma cells in vivo and in vitro, vasculogenic mimicry. Am J Pathol, 155, 739-752.
25. McClanahan T, Koseoglu S, Smith K, et al (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther, 5, 419-26.
26. Miraglia S, Godfrey W, Yin AH, et al (1997). A novel five-transmembrane hematopoietic stem cell antigen, isolation, characterization, and molecular cloning. Blood, 90, 5013-21.
27. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110.
28. Peichev M, Naiyer AJ, Pereira D, et al (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95, 952-8.
29. Rosen JM, Jordan CT (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324, 1670-3.
30. Sato T, Clevers H (2013). Growing self-organizing miniguts from a single intestinal stem cell, mechanism and applications. Science, 340, 1190-4.
31. Schneider M, Huber J, Hadaschik B, et al (2012). Characterization of colon cancer cells, a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer, 12, 96.
32. Scully S, Francescone R, Faibish M, et al (2012). Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci, 32, 12950-60.
33. Shirakawa K, Wakasugi H, Heike Y, et al (2002). Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer, 99, 821-8.
34. Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
35. Steg AD, Bevis KS, Katre AA, et al (2012). Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res, 18, 869-81.
36. Sun B, Qie S, Zhang S, et al (2008). Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol, 39, 445-51.
37. Sun B, Zhang S, Zhao X, Zhang W, Hao X (2004). Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol, 25, 1609-14.
38. Sun D, Sun B, Liu T, et al (2013). Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med, 17, 1038-47.
39. Sun W, Fan YZ, Zhang WZ, Ge CY (2011). A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res, 30, 46.
40. Tang HS, Feng YJ, Yao LQ (2009). Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Cancer, 19, 605-10.
41. Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108.
42. Valyi-Nagy K, Kormos B, Ali M, Shukla D, Valyi-Nagy T (2012). Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures. Mol Vis, 18, 588-92.
43. Vermeulen L, Todaro M, de Sousa Mello F, et al (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA, 105, 13427-32.
44. Wu S, Yu L, Wang D, et al (2012). Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer, 12, 535.
45. Wu XS, Xi HQ, Chen L (2012). Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol, 10, 244.
46. Yan X, Ma L, Yi D, et al (2011). A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A, 108, 1591-6.
47. Yang L, Levi E, Zhu S, Du J, Majumdar AP (2013). Cancer stem cells biomarkers in gastric carcinogenesis. J Gastrointest Cancer, 44, 428-35.
48. Yao X, Ping Y, Liu Y, et al (2013). Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One, 8, 57188.
49. Yin AH, Miraglia S, Zanjani ED, et al (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90, 5002-12.
50. Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M (2013). Investigating the link between molecular subtypes of glioblastoma epithelial-mesenchymal transition and CD133 cell surface protein. PLoS One, 8, 64169.
51. Zhang D, Sun B, Zhao X, et al (2014). Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Mol Cancer, 13, 207.
52. Zhang Y, Sun B, Zhao X, et al (2013). Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol, 49, 3914-23.
53. Zhao P, Li Y, Lu Y (2010). Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer, 10, 218.
54. Zhu L, Gibson P, Currle DS, et al (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature, 457, 603-7.